Cited by 17

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Presenilin1/γ‐secretase protects neurons from glucose deprivation‐induced death by regulating miR‐212 and PEA15

Huang, Qian, Voloudakis, Georgios, Ren, Yimin, Yoon, Yonejung, Zhang, Emily, Kajiwara, Yuji, Shao, Zhiping, Xuan, Zhao, Lebedev, Denis, Georgakopoulos, Anastasios, Robakis, Nikolaos K.·2018·The FASEB Journal

Abstract

Reduced cerebral glucose utilization is found in aged individuals and often is an early sign of neuro‐degeneration. Here, we show that under glucose deprivation (GD) conditions, decreased expression of presenilin 1 (PS1) results in decreased neuronal survival, whereas increased PS1 increases neuronal survival. Inhibition of γ‐secretase also decreases neuronal survival under GD conditions, which suggests the PS1/γ‐secretase system protects neurons from GD‐induced death. We also show that neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at ∼15 kDa (PEA15), and its mRNA are regulated by PS1/γ‐secretase. Furthermore, down‐regulation of PEA15 decreases neuronal survival under reduced glucose conditions, whereas exogenous PEA15 increases neuronal survival even in the absence of PS1, which indicates that PEA15 promotes neuronal survival under GD conditions. The absence or reduction of PS1, as well as γ‐secretase inhibitors, increases neuronal miR‐212, which targets PEA15 mRNA. PS1/γ‐secretase activates the transcription factor, cAMP response element‐binding protein, regulating miR‐212, which targets PEA15 mRNA. Taken together, our data show that under conditions of reduced glucose, the PS1/γ‐secretase system decreases neuronal losses by suppressing miR‐212 and increasing its target survival factor, PEA15. These observations have implications for mechanisms of neuronal death under conditions of reduced glucose and may provide targets for intervention in neurodegenerative disorders.—Huang, Q., Voloudakis, G., Ren, Y., Yoon, Y., Zhang, E., Kajiwara, Y., Shao, Z., Xuan, Z., Lebedev, D., Georgakopoulos, A., Robakis, N. K. Presenilin1/γ‐secretase protects neurons from glucose deprivation‐induced death by regulating miR‐212 and PEA15. FASEB J. 32, 243‐253 (2018). www.fasebj.org

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.201700447rr

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 57

  1. Blum‐Degen D., 1995, Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?, J. Neural Transm. Suppl., 46, 139
  2. 10.1196/annals.1427.007 · DOI
  3. 10.1186/1471-2202-9-S2-S16 · DOI · Paper page
  4. 10.1097/00002093-199505000-00005 · DOI
  5. 10.1016/0304-3940(95)11270-7 · DOI · Paper page
  6. Schöll M., 2011, Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers., J. Alzheimers Dis., 24, 495, 10.3233/JAD-2011-101563 · DOI
  7. 10.1523/JNEUROSCI.23-33-10681.2003 · DOI
  8. 10.1124/jpet.106.115550 · DOI
  9. 10.1371/journal.pone.0015008 · DOI · Paper page
  10. 10.1038/nrm1406 · DOI
  11. 10.1038/19077 · DOI
  12. 10.1523/JNEUROSCI.4067-07.2008 · DOI
  13. 10.1038/nature08177 · DOI
  14. Giannakopoulos P., 1997, Presenilin‐1‐immunoreactive neurons are preserved in late‐onset Alzheimer's disease., Am. J. Pathol., 150, 429
  15. 10.1016/j.neurobiolaging.2012.02.024 · DOI
  16. Mattson M. P., 2000, Presenilin‐1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvementof perturbed calcium homeostasis., J. Neurosci., 20, 1358, 10.1523/JNEUROSCI.20-04-01358.2000 · DOI
  17. 10.1038/jcbfm.2010.101 · DOI
  18. 10.1084/jem.20070823 · DOI · Paper page
  19. 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
  20. 10.1016/j.brainres.2010.03.106 · DOI
  21. Smith P. Y., 2015, miR‐132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum., Mol. Genet., 24, 6721
  22. 10.1038/emboj.2011.327 · DOI · Paper page
  23. 10.1016/j.pnpbp.2016.04.011 · DOI
  24. 10.1146/annurev.genom.8.080706.092351 · DOI
  25. 10.1093/emboj/21.8.1948 · DOI
  26. 10.1016/j.neurobiolaging.2011.06.017 · DOI
  27. 10.1158/0008-5472.CAN-04-0496 · DOI · Paper page
  28. Vandesompele J., 2002, Accurate normalization of real‐time quantitative RT‐PCR data by geometric averaging of multiple internal control genes., Genome Biol., 3, 10.1186/gb-2002-3-7-research0034 · DOI · Paper page
  29. Mosmann T., 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol., Methods, 65, 55
  30. 10.1096/fj.15-270645 · DOI
  31. 10.1073/pnas.1108225109 · DOI
  32. 10.1038/sj.emboj.7600251 · DOI
  33. 10.1083/jcb.149.4.793 · DOI
  34. 10.1158/0008-5472.CAN-09-3341 · DOI
  35. 10.1038/sj.onc.1210732 · DOI
  36. 10.1016/j.cell.2004.10.032 · DOI
  37. 10.1073/pnas.1015691107 · DOI · Paper page
  38. 10.1093/nar/gks151 · DOI
  39. 10.1016/S0896-6273(02)00828-0 · DOI · Paper page
  40. 10.1074/jbc.M113.499004 · DOI
  41. 10.1016/S1570-9639(02)00455-7 · DOI
  42. 10.1111/j.1749-6632.2000.tb05572.x · DOI
  43. 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I · DOI
  44. Leon M. J., 1993, The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation., AJNRAm.J. Neuroradiol., 14, 897
  45. 10.1007/s004150050387 · DOI · Paper page
  46. 10.1073/pnas.061509598 · DOI · Paper page
  47. 10.1001/archneurol.2012.590 · DOI
  48. 10.1096/fj.11-183806 · DOI
  49. 10.1016/j.cell.2003.08.008 · DOI
  50. Xu J., 2009, Peptide EphB2/CTF2 generated by the gamma‐secretase processing of EphB2 receptor promotes tyrosine phosphorylation and cell surface localization of N‐methyl‐D‐aspartate receptors. J. Biol., Chem., 284, 27220
  51. Auffret A., 2010, Progressive age‐related impairment of the late long‐term po‐ tentiation in Alzheimer's disease presenilin‐1 mutant knock‐in mice., J. Alzheimers Dis., 19, 1021, 10.3233/JAD-2010-1302 · DOI
  52. 10.1523/JNEUROSCI.2474-10.2010 · DOI
  53. 10.1016/j.neurobiolaging.2007.10.009 · DOI
  54. Estelies A., 1999, The phosphoprotein protein PEA‐15 inhibits Fas‐ but increases TNF‐R1‐mediated caspase‐8 activity and apoptosis., Dev. Biol., 216, 16, 10.1006/dbio.1999.9510 · DOI
  55. 10.1152/ajpendo.00228.2009 · DOI
  56. 10.1523/JNEUROSCI.5572-05.2006 · DOI
  57. Ramos J. W., 2009, Deletion of PEA‐15 in mice is associated with specific impairments of spatial learning abilities., BMC Neurosci., 10, 134, 10.1186/1471-2202-10-134 · DOI

Cited by

Sorted by citations

See all 17

Metadata

Authors
Huang, Q., Voloudakis, G., Ren, Y., Yoon, Y., Zhang, E., Kajiwara, Y., Shao, Z., Xuan, Z., Lebedev, D., Georgakopoulos, A., & Robakis, N. K.
Affiliations
Department of Psychiatry Icahn School of Medicine at Mount Sinai New York New York USA
Venue
The FASEB Journal
Publisher
Wiley
Published
2017-08-30
Volume
32
Issue
1
Pages
243-253
ISSN
  • 0892-6638
  • 1530-6860
Cited by
17
References
3
Language
en
Funders
  • National Institutes of Health
  • National Institute on Aging (AG17926, AG08200, AG05138)
  • National Institute of Neurological Disorders and Stroke (NS047229)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review